Delayed anthracycline-induced cardiomyopathy – case report
Journal Title: OncoReview - Year 2014, Vol 4, Issue 4
Abstract
43-year-old man was admitted to the hematology department due to second recurrence of anaplastic lymphoma T-cell ALK+. Lymphoma was diagnosed 28 years earlier. The patient received COP regimen (17 cycles) and CHOP (5 cycles), radiotherapy and underwent splenectomy. He achieved complete remission at that time. Relapse of the disease was diagnosed 8 years later, which was treated with 6 cycles of chemotherapy (cytarabine, mitoxantrone, vepeside and glucocorticoids) and high-dose chemotherapy followed by hematopoietic stem cell transplantation. Second disease recurrence was found in 2013, it was anaplastic lymphoma T-cell ALK+ stage IIA by Ann Arbor. Echocardiography and myocardial perfusion scintigraphy revealed chronic heart failure NYHA class I. Angiotensin receptor antagonist (ramipril) and β-blocker (carvedilol) were recommended. The patient underwent 6 cycles of ESHAP, complete remission was reported after the second cycle. High-dose therapy with autologous stem cell rescue was considered at that time. However, having T-cell ALK+ lymphoma with a relatively good prognosis, previous prolonged complete remissions (respectively – 12 and 8 years), an insufficient yield from the harvest (3,33 × 106/kg CD34+ cells), heart failure and chronic active viral hepatitis B, the high risk intensive chemotherapy followed by hematopoietic stem cells transplantation was discontinued. The chemotherapy was complicated by brachial vein and superficial vein thrombosis of left upper limb and hypogammaglobulinemia. Follow-up echocardiography performed after completion of chemotherapy showed improvement in EF (64%).
Authors and Affiliations
Elżbieta Wiater, Grzegorz Charliński, Małgorzata Magoń-Golińska
Keywords
Related Articles
- EP ID EP67768
- DOI -
- Views 199
- Downloads 0
Adjuvant imatinib after resection of gastrointestinal stromal tumour - systematic review and meta-analysis
[b]Background:[/b] Adjuvant therapy is recommended for population of patients with high risk of recurrence after resection of gastrointestinal stromal tumour.[b]The aim of the study:[/b] Evaluation of clinical efficacy a...
Squamous cell oesophageal cancer in retinoblastoma survivor: does germinal RB1 mutation influence chemo- and radiosensitivity?
The case of complete response of squamous cell oesophageal cancer to radiochemotherapy in patient previously operated due to hereditary retinoblastoma is presented. Second cancers in retinoblastoma survivors are the main...
Nuclear medicine diagnostic tools for early detection of myocardial damage in treated breast cancer patients
The most severe side effect in treated patients with breast cancer is treatment-induced cardiotoxicity, leading to chronic heart failure or CAD, and worsening the patient’s quality of life. The early detection and medica...
Therapy with liposomal doxorubicin in patients with advanced breast cancer after treatment with classical doxorubicin
Breast cancer is the most common female cancer in the world and in Poland. The improvement of diagnostic and therapeutic methods has led to patients’ longer life expectancy. It has also made breast cancer a chronic disea...
Clinical usefulness of measuring the number of Circulating Tumor Cells (CTC) in breast cancer patients
Background: Monitoring the breast cancer patients after an adjuvant therapy usually involves imaging methods or biopsy. Alternatively, breast cancer markers can be determined – one of them is the number of circulating tu...